Dr. Thomas J. Barclay, M.D. Radiology - Radiation Oncology Medicare: Medicare Enrolled Practice Location: 10291 44zs Road, Norwood, CO 81423 Phone: 970-729-2487 |
News Archive
But news outlets report that the computer and phone systems designed to address those appeals have yet to be launched. So far, an estimated 22,000 requests for fixes have been submitted via the mail.
A promising biomarker for the severity of age-related white matter changes (ARWMCs) and endothelial function was evaluated at Hiroshima University, Japan. The relationship between this biomarker, the telomeric 3'-overhang (G-tail) length, and cardiovascular risk in humans is unclear so far.
A powerful superbug, a hypervirulent form of the bacteria Klebsiella pneumoniae, is a very difficult to curb infection. It causes a variety of infections including rare but life-threatening liver, respiratory tract, bloodstream and other infections.
Alkermes, Inc. today announced positive preliminary results from a phase 3 clinical trial of naltrexone for extended-release injectable suspension (XR-NTX) for the treatment of opioid dependence. The six-month phase 3 study met its primary efficacy endpoint and data showed that patients treated once-monthly with XR-NTX demonstrated statistically significant higher rates of clean (opioid-free) urine screens, compared to patients treated with placebo, as measured by the cumulative distribution of clean urine screens (p<0.0002).
› Verified 6 days ago